Tailored antimicrobial therapy in critically ill patients

Antimicrobial resistance (AMR) continues to pose a challenge worldwide—especially when considering critically ill patients who require accurate and individualized therapy. Optimizing antimicrobial treatment today demands more than standard dosing approaches; it requires integrating laboratory data with real-time clinical insight.

In this case study, discover how Bologna University Hospital in Italy has implemented a comprehensive, interdisciplinary approach to tailored antimicrobial therapy. Prof. Federico Pea and his team, drive a program that combines definitive minimum inhibitory concentration (MIC) values, real-time therapeutic drug monitoring (TDM), and pharmacokinetic/pharmacodynamic (PK/PD) parameters to support informed therapeutic decisions. By aligning accurate microbiology data with patient-specific drug exposure, the team aims to improve clinical outcomes while helping to slow the emergence of antimicrobial resistance.

Learn directly from Prof. Pea about how this data-driven strategy is applied in daily clinical practice—and why it is becoming essential in modern antimicrobial stewardship.

Download the full case study “Tailored antimicrobial therapy in critically ill patients: the Bologna University Hospital approach” to explore their methodology, insights, and real-world impact.